CIK 0001638287
- Non-accelerated filer
- Smaller reporting company
MetaVia Inc.
Sign in to watch- Ticker
- MTVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472389984
- Phone
- +1 857-702-9600
- Business address
- 545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA, 02138
- Former names
- NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 19 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-03 | Price Ben Gil CEO and President | Grant or award · Nonstatutory Stock Option (right to buy) | +616,666 | 616,666 | ||
| 2021-09-02 | KOVEN ANDREW I Director | Grant or award · Nonstatutory Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2020-12-31 | Bakshi Akash SVP and COO | Grant or award | +29,013 | 29,013 | ||
| 2020-12-31 | Bakshi Akash SVP and COO | Grant or award | +855,059 | 884,072 | ||
| 2020-09-01 | Swirsky Douglas J Director | Grant or award · Non-qualified stock option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-13 | Salsbury Michael Director | Grant or award · Non-qualified stock option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-13 | Oh Jeong Gyun Director | Grant or award · Non-qualified stock option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-13 | Kim Na Yeon Director | Grant or award · Non-qualified stock option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-13 | Jeong Tae Heum Director | Grant or award · Non-qualified stock option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-13 | Gullans Steven R. Ph.D. Director | Grant or award · Non-qualified stock option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-13 | GROVES JASON L Director | Grant or award · Non-qualified stock option (right to buy) | +60,000 | 60,000 | ||
| 2019-12-30 | Versavel Mark Chief Medical Officer | Grant or award · Stock Option (right to buy) | +297,206 | 297,206 | ||
| 2019-12-30 | Versavel Mark Chief Medical Officer | Grant or award · Stock Option (right to buy) | +45,724 | 45,724 | ||
| 2019-12-30 | Oh Jeong Gyun Director | Grant or award | +1,817,842 | 1,817,842 | ||
| 2019-12-30 | Oh Jeong Gyun Director | Grant or award | +240,051 | 240,051 | ||
| 2019-12-30 | Kim Na Yeon Director | Grant or award | +4,335,800 | 4,335,800 | ||
| 2019-12-30 | Kim Na Yeon Director | Grant or award | +1,121,190 | 1,121,190 | ||
| 2019-12-30 | Kim Na Yeon Director | Grant or award | +1,864,799 | 1,864,799 | ||
| 2019-07-24 | SASSINE ANDY Director | Grant or award | +15,000 | 151,264 | ||
| 2019-07-24 | LICHTINGER PEDRO Director | Grant or award | +15,000 | 74,833 |
Page 4 of 7 · 135 trades